Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - therapeuticarea+%3e+rare%2fneglected+diseases
31
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Kinase Inhibitory Thiazines
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 4/22/2025
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application
,
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing
,
TherapeuticArea > Rare/Neglected Diseases
Reverse Thiazine Kinase Inhibitors
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 4/22/2025
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Licensing
,
TherapeuticArea > Rare/Neglected Diseases
Novel Kinase Inhibitory Aplithianines
Summary The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 5/14/2025
|
Inventor(s):
Barry O'Keefe
,
Lin Du
,
Brice Wilson
,
Ping Zhang
,
William Moore
,
Dongdong Wang
,
Juliana Martinez Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Therapeutics
,
TherapeuticArea > Oncology
,
TherapeuticArea > Infectious Disease
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Rare/Neglected Diseases
TYROSINASE Gene Therapy for Oculocutaneous Albinism type 1A
Summary: The National Eye Institute seeks research co-development partners and/or licensees for an adeno-associated viral gene therapy for Oculocutaneous Albinism type 1A. Description of Technology: Oculocutaneous albinism (OCA) is a genetically heterogeneous congenital disorder characterized by decreased or absent pigmentation in the hair,...
Published: 4/22/2025
|
Inventor(s):
Brian Brooks
,
Aman George
Keywords(s):
Category(s):
Application
,
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Ear, Nose, & Throat
,
Collaboration Sought > Licensing
,
TherapeuticArea > Rare/Neglected Diseases
Alpha-galactosidase-A Knockout Mouse Model for Studying Fabry Disease
This technology includes an alpha-galactosidase-A knockout mouse model that can be used to study Fabry disease, an X-linked lysosomal storage disorder. Alpha-galactosidase-A is a crucial enzyme responsible for the breakdown of glycolipids, particularly globotriaosylceramide (Gb3), within lysosomes. In Fabry disease, a rare and inherited lysosomal storage...
Published: 5/29/2025
|
Inventor(s):
Toshio Ohshima
,
Ashok Kulkarni
,
Roscoe Brady
,
Gary Murray
Keywords(s):
Category(s):
Application > Research Materials
,
Application > Therapeutics
,
Application > Vaccines
,
Collaboration Sought > Materials Available
,
ResearchProducts > Animal Models
,
TherapeuticArea > Metabolic Disease
,
TherapeuticArea > Rare/Neglected Diseases
Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
CDC researchers have developed a potent immunogenic enhancer polypeptide useful for improving flavivirus vaccines. Flaviviruses such as dengue virus (1, 2, 3 and 4), Japanese encephalitis virus, Murray Valley encephalitis virus, St. Louis encephalitis virus, yellow fever virus and tick-borne encephalitis virus are a great burden on public health. ...
Published: 4/24/2025
|
Inventor(s):
Holly Hughes
,
Gwong-Jen Chang
Keywords(s):
ADJUSTMENT
,
adjuvant
,
Adjuvant-like
,
BCXXXX
,
Boost
,
BOOSTING
,
CD4
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Cell
,
DB4BXX
,
DB4XXX
,
DC1XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
DENGUE
,
DENGUE FEVER
,
Dengue Vaccine
,
Dengue-1
,
Dengue-2
,
Dengue-Like
,
DXXXXX
,
Epitope
,
Flavivirus
,
FLAVIVIRUSES
,
Identification
,
in vivo
,
JAPANESE ENCEPHALITIS VIRUS
,
Listed LPM Houze as of 4/15/2015
,
Mosquito
,
Mosquitoes
,
Nile
,
OID-NCEZID-DVBD
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
PRIMER
,
T
,
THEREOF
,
Tick-Bone
,
TICK-BORNE
,
UBXXXX
,
Vaccine
,
Vaccine Design
,
VACCINE DEVELOPMENT
,
VBXXXX
,
Vector-borne
,
Vector-borne diseases
,
virus
,
VLXXXX
,
VOXXXX
,
WAXXXX
,
West
,
WIXXXX
,
WJXXXX
,
WMXXXX
,
XCXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Diagnostics
,
Application > Vaccines
,
Application > Therapeutics
,
Application > Research Materials
,
Application > Consumer Products
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Rare/Neglected Diseases
Entangling/Entrapping Synthetic Setae for Control of Insects and Other Pests
In nature, some beetle larvae possess specialized barbed hastate setae that serve as an entanglement defense mechanism and incapacitate other insects. CDC researchers have developed synthetic setae for control and entrapment of insects and other pests. While smaller synthetic setae can trap mosquitoes and small insects, larger “macro” setae can be...
Published: 5/9/2025
|
Inventor(s):
Robert Wirtz
Keywords(s):
AE2BXX
,
AE2XXX
,
AEXXXX
,
AFXXXX
,
AXXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
CGH-DPDM
,
CONTROL
,
DB2XXX
,
DB4XXX
,
DBXXXX
,
DEVICE
,
Devices
,
DEXXXX
,
DXXXXX
,
Entangling
,
Entrapment
,
insect
,
Insects
,
Mosquito
,
Mosquitoes
,
Net
,
Pest
,
Pests
,
population sampling
,
PXXXXX
,
Setae
,
TRAP
,
UBXXXX
,
UXXXXX
,
Vector-borne
,
Vector-borne diseases
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VOXXXX
,
WCXXXX
,
WDXXXX
,
WFXXXX
,
WIXXXX
,
WMXXXX
,
XDXXXX
,
XIXXXX
,
YFXXXX
,
Zoo
Category(s):
Collaboration Sought > Licensing
,
Application > Diagnostics
,
Application > Medical Devices
,
Application > Research Materials
,
Application > Occupational Safety and Health
,
Application > Non-Medical Devices
,
Application > Therapeutics
,
Application > Consumer Products
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Rare/Neglected Diseases
T24 Antigen for Diagnosing or Treating Taenia solium Cysticercosis
In order to develop a simple detection assay for field use, CDC researchers cloned and sequenced the Taenia solium T24 diagnostic protein. The T24 sequences can be used to detect and diagnose T. solium infection or can be formulated into a pharmaceutical composition. T. solium is a species of tapeworm. Intestinal infection with T. solium is referred...
Published: 5/9/2025
|
Inventor(s):
Fatima Williams
,
Melinda Yushak
,
Sowmya Pattabhi
,
Victor Tsang
,
Kathy Hancock
Keywords(s):
AFXXXX
,
ANTIGEN
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
CGH-DPDM
,
Cysticercosis
,
DA2XXX
,
DAXXXX
,
DB2XXX
,
DBXXXX
,
DC2XXX
,
DCXXXX
,
Immunodiagnosis
,
SOLIUM
,
T24
,
TAENIA
,
UBXXXX
,
UXXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
Application > Vaccines
,
Application > Diagnostics
,
TherapeuticArea > Rare/Neglected Diseases
Nucleic Acid Amplification Technique for Rapid Diagnostic Analysis
CDC researchers developed a simple target-specific isothermal nucleic acid amplification technique, termed Genome Exponential Amplification Reaction (GEAR). The method employs a set of four primers (two inner and two outer). The outer primer pair targets three specific nucleic acid sequences at a constant 60°C, while the inner pair of primers accelerates...
Published: 4/24/2025
|
Inventor(s):
Prithiviraj Jothikumar
,
Vincent Hill
,
Jothikumar Narayanan
Keywords(s):
AA2XXX
,
AA5XXX
,
AAXXXX
,
AC4XXX
,
AC5XXX
,
Acids
,
ACXXXX
,
amplification
,
AMPLIFYING
,
AXXXXX
,
DA1XXX
,
DA2XXX
,
DA3XXX
,
DA4XXX
,
DA5XXX
,
DAXXXX
,
DXXXXX
,
Exponential
,
Gear
,
Genome
,
Isothermal
,
Methods
,
Nucleic
,
REACTION
,
REAGENTS
,
UBXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Diagnostics
,
TherapeuticArea > Rare/Neglected Diseases
Multiplex Assay for Detection of Dengue Virus
Dengue virus (DENV) is the cause of dengue illness (dengue fever, dengue hemorrhagic fever, and dengue shock syndrome). CDC researchers have developed a RT-PCR multiplex assay that, prior to sero-conversion, selectively detects dengue virus in biological or other fluid media, such as whole blood, plasma, or serum. The primers and probes from this assay...
Published: 4/24/2025
|
Inventor(s):
Edgardo Vergne
,
Gilberto Santiago
,
Jorge Munoz-Jordan
Keywords(s):
Broad
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DENGUE
,
Detection
,
DXXXXX
,
Serotypes
,
UB1XXX
,
virus
Category(s):
Collaboration Sought > Licensing
,
Application > Diagnostics
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Rare/Neglected Diseases
1
2
3
4